Cardiovascular Safety of Oral p‐Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo‐Controlled Cross‐over Clinical Trial
暂无分享,去创建一个
[1] B. Rozec,et al. beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. , 2006, Pharmacology & therapeutics.
[2] R. Gougeon,et al. Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium. , 2005, Obesity research.
[3] P. Smits,et al. The cardiovascular effects of methylxanthines. , 2011, Handbook of experimental pharmacology.
[4] M. Jann,et al. Seville (sour) Orange Juice: Synephrine Content and Cardiovascular Effects in Normotensive Adults , 2001, Journal of clinical pharmacology.
[5] Vera Marisa Costa,et al. Synephrine: from trace concentrations to massive consumption in weight-loss. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[6] S. Benvenuti,et al. Chromatographic and electrophoretic methods for the analysis of phenetylamine alkaloids in Citrus aurantium , 2007 .
[7] S. Stohs,et al. Effects of p-Synephrine alone and in Combination with Selected Bioflavonoids on Resting Metabolism, Blood Pressure, Heart Rate and Self-Reported Mood Changes , 2011, International journal of medical sciences.
[8] P. Ambrose,et al. Blood Pressure and Heart Rate Effects Following a Single Dose of Bitter Orange , 2006, The Annals of pharmacotherapy.
[9] J. M. Midgley,et al. β‐Adrenergic activities of octopamine and synephrine stereoisomers on guinea‐pig atria and trachea , 1987, The Journal of pharmacy and pharmacology.
[10] Dangerous supplements: what you don't know about these 12 ingredients could hurt you. , 2010, Consumer reports.
[11] B. Patil,et al. Rapid simultaneous determination of amines and organic acids in citrus using high-performance liquid chromatography. , 2011, Talanta.
[12] B. Cain,et al. Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). , 2008, Journal of agricultural and food chemistry.
[13] S. Stohs,et al. A Review of the Receptor-Binding Properties of p-Synephrine as Related to Its Pharmacological Effects , 2011, Oxidative medicine and cellular longevity.
[14] J. Neuhaus,et al. Safety and efficacy of citrus aurantium for weight loss. , 2004, The American journal of cardiology.
[15] S. Stohs. Assessment of the adverse event reports associated with Citrus aurantium (bitter orange) from April 2004 to October 2009 , 2010 .
[16] N. Benowitz,et al. Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. , 2008, British journal of clinical pharmacology.
[17] N. Benowitz,et al. Hemodynamic effects of ephedra-free weight-loss supplements in humans. , 2005, The American journal of medicine.
[18] M. Shara,et al. A Review of the Safety and Efficacy of Citrus aurantium in Weight Management , 2007 .
[19] S. Wise,et al. Certification of standard reference materials containing bitter orange , 2008, Analytical and bioanalytical chemistry.
[20] C. White,et al. Absence of QTc‐Interval–Prolonging or Hemodynamic Effects of a Single Dose of Bitter‐Orange Extract in Healthy Subjects , 2005, Pharmacotherapy.
[21] I. Khan,et al. Simultaneous quantification of adrenergic amines and flavonoids in C. aurantium, various Citrus species, and dietary supplements by liquid chromatography. , 2005, Journal of AOAC International.
[22] S. Benvenuti,et al. High-performance liquid chromatography methods for the analysis of adrenergic amines and flavanones in Citrus aurantium L. var. amara. , 2004, Phytochemical analysis : PCA.
[23] Scott Sawler. Synephrine , Octopamine and Caffeine Health Risk Assessment ( HRA ) Report , 2011 .
[24] I. Khan,et al. Effects of synephrine and beta-phenethylamine on human alpha-adrenoceptor subtypes. , 2010, Planta medica.
[25] Harriet de Wit,et al. Genetics of caffeine consumption and responses to caffeine , 2010, Psychopharmacology.
[26] M. Inchiosa. Experience (Mostly Negative) with the Use of Sympathomimetic Agents for Weight Loss , 2010, Journal of obesity.
[27] J. Arch. β3-Adrenoceptor agonists: potential, pitfalls and progress , 2002 .
[28] S. Stohs,et al. A Review of the Human Clinical Studies Involving Citrus aurantium (Bitter Orange) Extract and its Primary Protoalkaloid p-Synephrine , 2012, International journal of medical sciences.
[29] J. Hengstmann,et al. [Pharmacokinetics and metabolism of 3H-synephrine (author's transl)]. , 1978, Arzneimittel-Forschung.
[30] E. Burke,et al. Effect of Acute Administration of an Herbal Preparation on Blood Pressure and Heart Rate in Humans , 2011, International journal of medical sciences.
[31] J. McGrath,et al. Activities of octopamine and synephrine stereoisomers on α‐adrenoceptors , 1988 .
[32] D. Perez,et al. The Unique Nature of the Serine Interactions for -Adrenergic Receptor Agonist Binding and Activation (*) , 1996, The Journal of Biological Chemistry.
[33] S. Stohs,et al. The Safety of Citrus aurantium (Bitter Orange) and its Primary Protoalkaloid p‐Synephrine , 2011, Phytotherapy research : PTR.
[34] S. Stohs,et al. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[35] A. Fugh-Berman,et al. Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss: Current Status of Clinical and Basic Research , 2004, Experimental biology and medicine.